A new optimized method for the determination of fibrin clot permeability

Blood Coagulation and Fibrinolysis

Volumn 16, Issue 8, 2005, Pages 579-583

  Sjøland, Jonas A ^a,b  

^a ESBJERG HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Coefficient of variation; Fibrin clot permeability; Fibrin structure; Fibrinogen; Plasma; Reference interval; Reproducibility

Indexed keywords

ADULT; ARTICLE; FEMALE; FIBRIN CLOT; HUMAN; MALE; MEASUREMENT; NORMAL HUMAN; PERMEABILITY; PRIORITY JOURNAL; REFERENCE VALUE; TECHNIQUE; VOLUNTEER;

EID: 27844475637     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000187264.02317.e3     Document Type: Article

References (16)

1. Sidelmann JJ, Gram J, Jespersen J, Kluft C. Fibrin clot formation and lysis: basic mechanisms. Semin Thromb Hemost 2000; 26:605-618.
2. Ariëns RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 2002; 100:743-754.
3. Blombäck B, Carlsson K, Hessel B, Liljeborg A, Procyk R, Åslund N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta 1989; 997:96-110.
4. Collet JP, Nagaswami C, Farrell DH, Montalescot G, Weisel JW. Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate. Arterioscler Thromb Vasc Biol 2004; 24:382-386.
5. Blombäck B, Okada M. Fibrin gel structure and clotting time. Thromb Res 1982;25:51-70.
6. Signer R, Egli H. Sedimentation von makromolekülen und durchströmung von gelen. Rec Trav Chim 1950; 69:45-58.
7. Carr ME Jr, Shen LL, Hermans J. Mass-length ratio of fibrin fibers from gel permeation and light scattering. Biopolymers 1977; 16:1-15.
8. Jörneskog G, Hansson LO, Wallen NH, Yngen M, Blombäck M. Increased plasma fibrin gel porosity in patients with Type I diabetes during continuous subcutaneous insulin infusion. J Thromb Haemost 2003; 1:1195-1201.
9. Collet JP, Mishal Z, Lesty C, Mirshahi M, Peyne J, Baumelou A, et al. Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Thromb Haemost 1999; 82:1482-1489.
10. He S, Cao H, Antovic A, Blombäck M. Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials. Blood Coagul Fibrinolysis 2005; 16:61-67.
11. Ariëns RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000; 96:988-995.
12. Nair CH, Azhar A, Dhall DP. Studies on fibrin network structure in human plasma. Part one: methods for clinical application. Thromb Res 1991; 64:455-476.
13. Woodhead JL, Nagaswami C, Matsuda M, Arocha-Pinango CL, Weisel JW. The ultrastructure of fibrinogen Caracas Il molecules, fibers, and clots. J Biol Chem 1996; 271:4946-4953.
14. Williams S, Fatah K, Hjemdahl P, Blombäck M. Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid. Eur Heart J 1998; 19:1666-1672.
15. Fatah K, Silveira A, Tornvall P, Karpe F, Blombäck M, Hamsten A. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost 1996; 76:535-540.
16. Pieters M, Jerling JC, Weisel JW. Effect of freeze-drying, freezing and frozen storage of blood plasma on fibrin network characteristics. Thromb Res 2002; 107:263-269.